Medical Treatment of Later-Stage Motor Problems of Parkinson Disease
- 1 December 1999
- journal article
- review article
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 74 (12) , 1239-1254
- https://doi.org/10.4065/74.12.1239
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Adverse reactions to levodopa: drug toxicity or progression of disease?The Lancet, 1998
- The Significance of Continuous Dopaminergic Stimulation in the Treatment of Parkinson??s DiseaseDrugs, 1998
- Treatment of Early Parkinson's Disease: Are Complicated Strategies Justified?Mayo Clinic Proceedings, 1996
- Fluctuating Parkinson's DiseaseArchives of Neurology, 1994
- Motor fluctuations in levodopa treated parkinsonian rats: relation to lesion extent and treatment durationBrain Research, 1994
- Continuous lisuride effects on central dopaminergic mechanisms in Parkinson's diseaseAnnals of Neurology, 1992
- Modification of central dopaminergic mechanisms by continuous levodopa therapy for advanced Parkinson's diseaseAnnals of Neurology, 1990
- Brain dopamine metabolism in patients with Parkinson's disease measured with positron emission tomography.Journal of Neurology, Neurosurgery & Psychiatry, 1986
- Permanent human parkinsonism due to 1‐methy 1–4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)Neurology, 1985
- The “On–Off” Phenomenon in Parkinson’s DiseaseNew England Journal of Medicine, 1984